Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021

by Sandeep Sehdev, Alexandra Chambers
Published 2022-03-01

Biosimilars in oncology in Canada and the role of nurses

by Sandeep Sehdev, Karyn Perry, Kathy Gesy
Published 2019-10-01

Les médicaments biosimilaires en oncologie au canada : rôle des infirmières

by Sandeep Sehdev, Karyn Perry, Kathy Gesy
Published 2019-10-01

Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action

by Sandeep Sehdev, Joanna Gotfrit, Martine Elias, Barry D. Stein
Published 2024-03-01

Access Denied? The Unintended Consequences of Pending Drug Pricing Rules

by Alan Kaplan, David J. Stewart, Gerald Batist, Silvana Spadafora, Sandeep Sehdev, Shaun G. Goodman
Published 2022-04-01

Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic

by Tabitha Tse, Sandeep Sehdev, Jean Seely, Denis H. Gravel, Mark Clemons, Erin Cordeiro, Angel Arnaout
Published 2021-03-01

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm

by Charlie Yang, Christine Brezden-Masley, Anil Abraham Joy, Sandeep Sehdev, Shanu Modi, Christine Simmons, Jan-Willem Henning
Published 2023-06-01

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain

by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia
Published 2022-12-01

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc...

by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia
Published 2023-05-01

HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review

by Katarzyna J. Jerzak, Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton, Sandeep Sehdev
Published 2023-06-01

Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation

by Sharon McGee, Mashari AlZahrani, Carol Stober, Terry L. Ng, Katherine Cole, Gail Larocque, Arif Awan, Sandeep Sehdev, John Hilton, Lisa Vandermeer, Brian Hutton, Gregory Pond, Deanna Saunders, Mark Clemons
Published 2021-04-01

New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices

by David J. Stewart, John-Peter Bradford, Sandeep Sehdev, Tim Ramsay, Vishal Navani, Nigel S. B. Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan Kaplan, Silvana Spadafora, Shaun G. Goodman, Rebecca A. C. Auer, Gerald Batist
Published 2024-04-01

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Pa...

by Kim A. Papp, Barbara Melosky, Sandeep Sehdev, Sebastien J. Hotte, Jennifer R. Beecker, Mark G. Kirchhof, Irina Turchin, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles W. Lynde, Vimal H. Prajapati, Ronald B. Vender
Published 2023-07-01

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

by Kim A. Papp, Barbara Melosky, Sandeep Sehdev, Sebastien J. Hotte, Jennifer R. Beecker, Mark G. Kirchhof, Irina Turchin, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles W. Lynde, Vimal H. Prajapati, Ronald B. Vender
Published 2023-03-01